These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2344828

  • 21. [The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].
    Donenko FV, Sitdikova SM, Kabieva AO.
    Biull Eksp Biol Med; 1993 Sep; 116(9):309-11. PubMed ID: 8118011
    [Abstract] [Full Text] [Related]

  • 22. [Antineoplastic and curative antileukemic activity of 1,4-benzoquinone guanylhydrazone thiosemicarbazone and its hydrochloride on in vivo murine models].
    Gutsche W, Schulze W, Jungstand W, Wohlrabe K.
    Pharmazie; 1983 Feb; 38(2):105-7. PubMed ID: 6856662
    [Abstract] [Full Text] [Related]

  • 23. [Gene amplification in murine leukemia cells with multiple drug resistance acquired in vivo].
    Demidova NS, Goncharova SA, Chernova OB, Kopnin BP, Gudkov AV.
    Genetika; 1987 Oct; 23(10):1797-806. PubMed ID: 3692152
    [Abstract] [Full Text] [Related]

  • 24. [Cytological characteristics of carminomycin-resistant P-388 lymphoid leukosis].
    Kozinets GI, Ivanova E, Kuznetsova TV, Khanykova OK, Levina NV.
    Eksp Onkol; 1985 Oct; 7(4):60-4, 76. PubMed ID: 4042959
    [Abstract] [Full Text] [Related]

  • 25. [Cytostatic action of N-ethyl-13-dihydrorubomycin on the cells of various tumor strains].
    Volkolupova OP.
    Antibiotiki; 1984 Jun; 29(6):435-7. PubMed ID: 6548103
    [Abstract] [Full Text] [Related]

  • 26. [Results of random screening of possible antineoplastic agents in Japan using mouse cancer. 3].
    Gan To Kagaku Ryoho; 1984 Sep; 11(9 Pt 2):1899-2096. PubMed ID: 6497404
    [No Abstract] [Full Text] [Related]

  • 27. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
    Yang JM, Goldenberg S, Gottesman MM, Hait WN.
    Cancer Res; 1994 Feb 01; 54(3):730-7. PubMed ID: 7905786
    [Abstract] [Full Text] [Related]

  • 28. Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.
    Ganapathi R, Grabowski D, Schmidt H, Seshadri R, Israel M.
    Biochem Biophys Res Commun; 1985 Sep 16; 131(2):912-9. PubMed ID: 2932108
    [Abstract] [Full Text] [Related]

  • 29. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
    Ramu A, Cohen L, Glaubiger D.
    Cancer Res; 1984 May 16; 44(5):1976-80. PubMed ID: 6324993
    [Abstract] [Full Text] [Related]

  • 30. Calcium, calmodulin, and protein content of adriamycin-resistant and -sensitive murine leukemic cells.
    Nair S, Samy TS, Krishan A.
    Cancer Res; 1986 Jan 16; 46(1):229-32. PubMed ID: 3940193
    [Abstract] [Full Text] [Related]

  • 31. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T, Oh-Hara T, Sudo Y, Naito M.
    Anticancer Res; 1993 Jan 16; 13(2):357-61. PubMed ID: 8517647
    [Abstract] [Full Text] [Related]

  • 32. Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.
    Sehested M, Skovsgaard T, van Deurs B, Winther-Nielsen H.
    Br J Cancer; 1987 Dec 16; 56(6):747-51. PubMed ID: 3435701
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
    Ganapathi R, Grabowski D.
    Cancer Res; 1983 Aug 16; 43(8):3696-9. PubMed ID: 6861140
    [Abstract] [Full Text] [Related]

  • 35. Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.
    Satyamoorthy K, Deshpande SS, Chitnis MP.
    Neoplasma; 1989 Aug 16; 36(6):673-83. PubMed ID: 2515459
    [Abstract] [Full Text] [Related]

  • 36. Flow cytometric screening for selective toxicity to multidrug-resistant cells.
    Frankfurt OS.
    J Natl Cancer Inst; 1987 Oct 16; 79(4):831-6. PubMed ID: 3477663
    [Abstract] [Full Text] [Related]

  • 37. Biological characterization of three new spontaneous mouse lymphomas and comparison with the leukemia P388.
    Baumgart J, Güttner J, Zborowska E, Czarnomska A.
    Arch Geschwulstforsch; 1988 Oct 16; 58(4):223-33. PubMed ID: 3421809
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.